Skip to main content

Day: July 27, 2024

ALIM ALERT: The M&A Class Action Firm Investigates Merger of The Alimera Sciences, Inc.

New York, July 27, 2024 (GLOBE NEWSWIRE) — NEW YORK, July 27, 2024 / GlobeNewswire/– Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Alimera Sciences, Inc. (Nasdaq: ALIM), relating to its proposed merger with ANI Pharmaceuticals, Inc. Under the terms of the agreement, Alimera Sciences shareholders will receive $5.50 per share, and one contingent value right which shall represent the right to receive up to $0.50 per share contingent on reaching certain net revenue targets in 2026 and 2027.  Click here for more information https://monteverdelaw.com/case/alimera-sciences-inc/. It is free...

Continue reading

ALE INVESTIGATION: The M&A Class Action Firm Continues to Investigate the Merger and August 21, 2024 Shareholder Vote of ALLETE, Inc.

NEW YORK, July 27, 2024 (GLOBE NEWSWIRE) — NEW YORK, July 27, 2024 / GobeNewswire/– Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and is investigating ALLETE, Inc. (NYSE: ALE), relating to its proposed merger with a partnership led by Canada Pension Plan Investment Board and Global Infrastructure Partners. Under the terms of the agreement, ALLETE stockholders will receive $67.00 per share in cash for each share of common stock owned as of the closing of the transaction. THIS IS YOUR CHANCE TO ACT. The Shareholder Vote is scheduled for August 21, 2024. Click here for more information https://monteverdelaw.com/case/allete-inc/....

Continue reading

SHAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger and Upcoming Vote on August 27, 2024, of Doma Holdings, Inc. – DOMA

NEW YORK, July 27, 2024 (GLOBE NEWSWIRE) — NEW YORK, July 27, 2024 / GlobeNewswire/– Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and is investigating Doma Holdings, Inc. (NYSE: DOMA), relating to its proposed sale to Title Resources Group. Under the terms of the agreement, DOMA shareholders are expected to receive $6.29 in cash per share they own. THE TIME TO ACT IS NOW. The Shareholder Vote is scheduled for August 27, 2024. Click here for more information: https://monteverdelaw.com/case/doma-holdings-inc/. It is free and there is no cost or obligation to you. Before you hire a law firm, you should talk...

Continue reading

BALY INVESTIGATION: The M&A Class Action Firm Launches Investigation Merger of Bally’s Corp.

NEW YORK, July 27, 2024 (GLOBE NEWSWIRE) — NEW YORK, July 27, 2024 / GlobeNewswire/– Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Bally’s Corp. (NYSE: BALY), relating to its proposed merger with Standard General L.P. Under the terms of the agreement, Bally’s Corp stockholders will receive $18.25 in cash per share they own.    Click here for more information https://monteverdelaw.com/case/ballys-corp/.  It is free and there is no cost or obligation to you. Before you hire a law firm, you should talk to a lawyer and ask:Do you file class actions and go to Court? When was the last...

Continue reading

COFS ALERT: The M&A Class Action Firm Launches Investigation of the Merger of ChoiceOne Financial Services, Inc.

NEW YORK, July 27, 2024 (GLOBE NEWSWIRE) — NEW YORK, July 26, 2024 Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating ChoiceOne Financial Services, Inc. (Nasdaq: COFS), relating to its proposed merger with Fentura Financial, Inc. Under the terms of the agreement, ChoiceOne stockholders will receive 1.35 shares of Fentura stock per share of ChoiceOne stock they own.    Click here for more information https://monteverdelaw.com/case/choiceone-financial-services-inc/.  It is free and there is no cost or obligation to you. Before you hire a law firm, you should talk to a lawyer and ask:Do you file...

Continue reading

STOCKHOLDER ALERT: The M&A Class Action Firm Is Investigating the Merger and its Tender Offer for Calliditas Therapeutics AB – CALT

NEW YORK, July 27, 2024 (GLOBE NEWSWIRE) — NEW YORK, July 27, 2024 / GlobeNewswire/– Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered money for shareholders and is recognized as a Top 50 Firm in the 2018-2022 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating Calliditas Therapeutics AB (NASDAQ: CALT), relating to a tender offer from Asahi Kasei Corporation. Under the terms of the offer, Asahi Kasei Corporation will acquire all the outstanding shares of Calliditas stock for SEK 0.04 in cash per ADS. ACT NOW. The Tender Offer will expire on August 30, 2024. Click here for more information https://monteverdelaw.com/case/calliditas-therapeutics-ab/.  It is free and there is no cost or obligation to you. Before...

Continue reading

Rakovina Therapeutics Closes Previously Announced Over-subscribed Private Placement

All dollar amounts reflected in Canadian dollars unless otherwise stated. VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) — Rakovina Therapeutics Inc. (TSX-V: RKV) (the “Company”), a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies, announces that, further to the press releases dated May 23, 2024, June 20, 2024, July 19, 2024, and July 22, 2024, the Company has closed its previously announced over-subscribed non-brokered private placement (the “Private Placement”) for gross proceeds to the Company of $2 million. In connection with the Private Placement, the Company issued 19,950,000 units (each, a “Unit”) at a purchase price of $0.10 per Unit. Each Unit is comprised of one common share of the Company (each, a “Common Share”) and one Common Share purchase...

Continue reading

Alaska Energy Metals Announces Marketing Program Addition

VANCOUVER, British Columbia, July 26, 2024 (GLOBE NEWSWIRE) — Alaska Energy Metals Corporation (TSX-V: AEMC, OTCQB: AKEMF) (“Alaska Energy Metals”, the “Company”, or “AEMC”) today announced additional marketing services with Gold Standard Media. Further to its news release of July 16, 2024, announcing the 90-day renewal of its marketing services agreement with Gold Standard Media, LLC (“Gold Standard”), the Company has decided to increase the scope of Gold Standard’s services to include additional financial publishing and digital marketing services. In return for the additional services to be provided, the Company has agreed to increase Gold Standard’s fee from USD$150,000 (approximately CAD$206,400) to USD$250,000 (approximately CAD$345,260). The terms of the Company’s engagement with Gold Standard remain unchanged. Gold Standard...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.